TRAX (First Tracks Biotherapeutics, Inc. Ordinary Shares)
Insider Trading Activity
Every open-market purchase and sale reported by TRAX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | J. Anthony Ware | Director | MIXED | — | — |
| 2026-08-18 | BENJAMIN STONE | Chief Business Officer | A | — | — |
| 2026-08-18 | Daniel Faga | President, CEO | A | — | — |
| 2026-08-18 | Paul F. Lizzul | Chief Medical Officer | A | — | — |
| 2026-08-05 | Daniel Faga | President, CEO | A | — | — |
| 2026-08-05 | Paul F. Lizzul | Chief Medical Officer | A | — | — |
| 2026-08-05 | BENJAMIN STONE | Chief Business Officer | A | — | — |
| 2026-06-17 | John P. Schmid | Director | M | — | — |
| 2026-06-17 | Rita Jain | Director | M | — | — |
| 2026-06-17 | DENNIS M FENTON | Director | M | — | — |
| 2026-06-17 | John A Orwin | Director | M | — | — |
| 2026-06-17 | J. Anthony Ware | Director | M | — | — |
| 2026-06-17 | Magda Marquet | Director | M | — | — |
| 2026-06-12 | Rita Jain | Director | A | — | — |
| 2026-06-12 | Magda Marquet | Director | A | — | — |
| 2026-06-12 | John P. Schmid | Director | A | — | — |
| 2026-06-12 | John A Orwin | Director | A | — | — |
| 2026-06-12 | DENNIS M FENTON | Director | A | — | — |
| 2026-06-12 | J. Anthony Ware | Director | A | — | — |
| 2026-05-14 | DENNIS M FENTON | Director | A | — | — |
| 2026-05-14 | Ajim Tamboli | Chief Financial Officer | A | — | — |
| 2026-05-14 | J. Anthony Ware | Director | A | — | — |
| 2026-05-14 | John P. Schmid | Director | A | — | — |
| 2026-05-14 | Magda Marquet | Director | A | — | — |
| 2026-05-14 | Paul F. Lizzul | Chief Medical Officer | A | — | — |
| 2026-05-14 | BENJAMIN STONE | Chief Business Officer | A | — | — |
| 2026-05-14 | John A Orwin | Director | A | — | — |
| 2026-05-14 | Rita Jain | Director | A | — | — |
| 2026-05-14 | Daniel Faga | President, CEO | A | — | — |
| 2026-04-23 | Ajim Tamboli | Chief Financial Officer | A | — | — |
| 2026-04-22 | EcoR1 Capital, LLC | 10%+ Owner | Sell | — | — |
| 2026-04-22 | ANAPTYSBIO, INC | 10%+ Owner | J | — | — |
| 2026-04-22 | John A Orwin | Director | A | — | — |
| 2026-04-22 | DENNIS M FENTON | Director | A | — | — |
| 2026-04-22 | Daniel Faga | President, CEO | A | — | — |
| 2026-04-22 | Magda Marquet | Director | A | — | — |
| 2026-04-22 | Rita Jain | Director | A | — | — |
| 2026-04-22 | John P. Schmid | Director | A | — | — |
| 2026-04-22 | Paul F. Lizzul | Chief Medical Officer | A | — | — |
| 2026-04-22 | J. Anthony Ware | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 3,174,519 | — |
| — | President, CEO | 496,684 | — |
| — | Chief Medical Officer | 42,669 | — |
| — | Director | 37,652 | — |
| — | Director | 19,194 | — |
| — | Director | 16,695 | — |
| — | Director | 15,960 | — |
| — | Director | 15,660 | — |
| — | Director | 10,995 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the TRAX quote page; the site-wide leaderboard is on the insider transactions hub.